Next Generation Sequencing Market By PRODUCT, By APPLICATION, By TECHNOLOGY, By END USER : Global Opportunity Analysis and Industry Forecast, 2024-2035

Description

List of Tables

The next generation sequencing market was valued at $ 13 billion in 2023 and is estimated to reach $97.8 billion by 2035, exhibiting a CAGR of 18.3% from 2024 to 2035. Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS, also known as deep sequencing and parallel sequencing, is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.The major factors driving the growth of the NGS market include rise in technological advancements, rise in the number of collaborations & partnerships to promote the use of NGS in hospitals & research centers, and increase in genome mapping programs throughout the world. For instance, in March 2023, Qiagen N.V. N.V. announced the launch of the new QIAseq Platform Partnership program and the first partnership with medical data-analysis provider SOPHiA GENETICSTM that will bring together its QIAseq technology for next-generation sequencing (NGS) with the SOPHiA DDMTM digital analytics platform. Similarly, in June 2021, Labcorp, a global leading life science company, and OmniSeq, a molecular diagnostic of Rosewell Park Comprehensive Cancer Center, together announced the launch of OmniSeq INSIGHT, which is a next generation sequencing platform to advance the precision oncology and improve patient outcome.The next generation sequencing market is segmented into product, application, technology, end user, and region. By product, the market is classified into consumables, platforms, and services. On the basis of application, the market is fragmented into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. On the basis of technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. By end user, the market is divided into academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, North Africa, Middle East & Africa).The key players that operate in the next generation sequencing market are Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., PerkinElmer, Inc., PierianDx Inc., Qiend usern N.V., and Thermo Fisher Scientific Inc. The key players have adopted product launch, product development, collaboration, partnership, and product approval as the key strategies to strengthen their foothold in the competitive market.

Next Generation Sequencing Market - IMG1

Key Benefits for StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the next generation sequencing market analysis from 2023 to 2035 to identify the prevailing next generation sequencing market opportunities.The market research is offered along with information related to key drivers, restraints, and opportunities.Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.In-depth analysis of the next generation sequencing market segmentation assists to determine the prevailing market opportunities.Major countries in each region are mapped according to their revenue contribution to the global market.Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.The report includes the analysis of the regional as well as global next generation sequencing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By TECHNOLOGY

Sequencing by synthesis (SBS)
Ion semiconductor sequencing (IOS)
Sequencing by Ligation (SBL)
Pyrosequencing
Single-molecule-real-time sequencing (SMRT)
Others

By END USER

Academic and clinical research centers
Pharmaceutical and biotechnology companies
Hospitals and clinics
Others

By PRODUCT

Consumables
- Type
- Sample Preparation Consumables◦
- Type
- Other Consumables
Platforms
- Type
- MiSeq
- Ion Torrent
- SOLiD
- Pacbio Rs II and Sequel System
- Others
Services
- Type
- Sequencing Services◦
- Type
- Data Management Services◦
- Type

By APPLICATION

Diagnostics
Biomarkers and Cancer
Reproductive Health
Personalized medicine
Agriculture and animal research
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

ILLUMINA INC.
F. HOFFMANN-LA ROCHE AG
Qiagen N.V
abgi group
PerkinElmer, Inc
Agilent Technologies, Inc.
Pacific Biosciences of California
Thermo Fisher Scientific Inc.
PRECIGEN INC

Product Code: A01718

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Consumables
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Consumables Next Generation Sequencing Market by Type
  - 4.2.4.1. Sample Preparation Consumables Next Generation Sequencing Market by Type
4.3. Platforms
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Platforms Next Generation Sequencing Market by Type
4.4. Services
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.4.4. Services Next Generation Sequencing Market by Type
  - 4.4.4.1. Sequencing Services Next Generation Sequencing Market by Type
  - 4.4.4.2. Data Management Services Next Generation Sequencing Market by Type

CHAPTER 5: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Diagnostics
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Biomarkers and Cancer
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Reproductive Health
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Personalized medicine
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
5.6. Agriculture and animal research
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
5.7. Others
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country

CHAPTER 6: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Sequencing by synthesis (SBS)
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Ion semiconductor sequencing (IOS)
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Sequencing by Ligation (SBL)
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. Pyrosequencing
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
6.6. Single-molecule-real-time sequencing (SMRT)
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
6.7. Others
- 6.7.1. Key market trends, growth factors and opportunities
- 6.7.2. Market size and forecast, by region
- 6.7.3. Market share analysis by country

CHAPTER 7: NEXT GENERATION SEQUENCING MARKET, BY END USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Academic and clinical research centers
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Pharmaceutical and biotechnology companies
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Hospitals and clinics
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
7.5. Others
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country

CHAPTER 8: NEXT GENERATION SEQUENCING MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by PRODUCT
- 8.2.3. Market size and forecast, by APPLICATION
- 8.2.4. Market size and forecast, by TECHNOLOGY
- 8.2.5. Market size and forecast, by END USER
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Market size and forecast, by PRODUCT
  - 8.2.6.1.2. Market size and forecast, by APPLICATION
  - 8.2.6.1.3. Market size and forecast, by TECHNOLOGY
  - 8.2.6.1.4. Market size and forecast, by END USER
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Market size and forecast, by PRODUCT
  - 8.2.6.2.2. Market size and forecast, by APPLICATION
  - 8.2.6.2.3. Market size and forecast, by TECHNOLOGY
  - 8.2.6.2.4. Market size and forecast, by END USER
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Market size and forecast, by PRODUCT
  - 8.2.6.3.2. Market size and forecast, by APPLICATION
  - 8.2.6.3.3. Market size and forecast, by TECHNOLOGY
  - 8.2.6.3.4. Market size and forecast, by END USER
8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by PRODUCT
- 8.3.3. Market size and forecast, by APPLICATION
- 8.3.4. Market size and forecast, by TECHNOLOGY
- 8.3.5. Market size and forecast, by END USER
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Market size and forecast, by PRODUCT
  - 8.3.6.1.2. Market size and forecast, by APPLICATION
  - 8.3.6.1.3. Market size and forecast, by TECHNOLOGY
  - 8.3.6.1.4. Market size and forecast, by END USER
  - 8.3.6.2. France
  - 8.3.6.2.1. Market size and forecast, by PRODUCT
  - 8.3.6.2.2. Market size and forecast, by APPLICATION
  - 8.3.6.2.3. Market size and forecast, by TECHNOLOGY
  - 8.3.6.2.4. Market size and forecast, by END USER
  - 8.3.6.3. UK
  - 8.3.6.3.1. Market size and forecast, by PRODUCT
  - 8.3.6.3.2. Market size and forecast, by APPLICATION
  - 8.3.6.3.3. Market size and forecast, by TECHNOLOGY
  - 8.3.6.3.4. Market size and forecast, by END USER
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Market size and forecast, by PRODUCT
  - 8.3.6.4.2. Market size and forecast, by APPLICATION
  - 8.3.6.4.3. Market size and forecast, by TECHNOLOGY
  - 8.3.6.4.4. Market size and forecast, by END USER
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Market size and forecast, by PRODUCT
  - 8.3.6.5.2. Market size and forecast, by APPLICATION
  - 8.3.6.5.3. Market size and forecast, by TECHNOLOGY
  - 8.3.6.5.4. Market size and forecast, by END USER
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Market size and forecast, by PRODUCT
  - 8.3.6.6.2. Market size and forecast, by APPLICATION
  - 8.3.6.6.3. Market size and forecast, by TECHNOLOGY
  - 8.3.6.6.4. Market size and forecast, by END USER
8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by PRODUCT
- 8.4.3. Market size and forecast, by APPLICATION
- 8.4.4. Market size and forecast, by TECHNOLOGY
- 8.4.5. Market size and forecast, by END USER
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. Japan
  - 8.4.6.1.1. Market size and forecast, by PRODUCT
  - 8.4.6.1.2. Market size and forecast, by APPLICATION
  - 8.4.6.1.3. Market size and forecast, by TECHNOLOGY
  - 8.4.6.1.4. Market size and forecast, by END USER
  - 8.4.6.2. China
  - 8.4.6.2.1. Market size and forecast, by PRODUCT
  - 8.4.6.2.2. Market size and forecast, by APPLICATION
  - 8.4.6.2.3. Market size and forecast, by TECHNOLOGY
  - 8.4.6.2.4. Market size and forecast, by END USER
  - 8.4.6.3. India
  - 8.4.6.3.1. Market size and forecast, by PRODUCT
  - 8.4.6.3.2. Market size and forecast, by APPLICATION
  - 8.4.6.3.3. Market size and forecast, by TECHNOLOGY
  - 8.4.6.3.4. Market size and forecast, by END USER
  - 8.4.6.4. Australia
  - 8.4.6.4.1. Market size and forecast, by PRODUCT
  - 8.4.6.4.2. Market size and forecast, by APPLICATION
  - 8.4.6.4.3. Market size and forecast, by TECHNOLOGY
  - 8.4.6.4.4. Market size and forecast, by END USER
  - 8.4.6.5. South Korea
  - 8.4.6.5.1. Market size and forecast, by PRODUCT
  - 8.4.6.5.2. Market size and forecast, by APPLICATION
  - 8.4.6.5.3. Market size and forecast, by TECHNOLOGY
  - 8.4.6.5.4. Market size and forecast, by END USER
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Market size and forecast, by PRODUCT
  - 8.4.6.6.2. Market size and forecast, by APPLICATION
  - 8.4.6.6.3. Market size and forecast, by TECHNOLOGY
  - 8.4.6.6.4. Market size and forecast, by END USER
8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by PRODUCT
- 8.5.3. Market size and forecast, by APPLICATION
- 8.5.4. Market size and forecast, by TECHNOLOGY
- 8.5.5. Market size and forecast, by END USER
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Market size and forecast, by PRODUCT
  - 8.5.6.1.2. Market size and forecast, by APPLICATION
  - 8.5.6.1.3. Market size and forecast, by TECHNOLOGY
  - 8.5.6.1.4. Market size and forecast, by END USER
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Market size and forecast, by PRODUCT
  - 8.5.6.2.2. Market size and forecast, by APPLICATION
  - 8.5.6.2.3. Market size and forecast, by TECHNOLOGY
  - 8.5.6.2.4. Market size and forecast, by END USER
  - 8.5.6.3. South Africa
  - 8.5.6.3.1. Market size and forecast, by PRODUCT
  - 8.5.6.3.2. Market size and forecast, by APPLICATION
  - 8.5.6.3.3. Market size and forecast, by TECHNOLOGY
  - 8.5.6.3.4. Market size and forecast, by END USER
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Market size and forecast, by PRODUCT
  - 8.5.6.4.2. Market size and forecast, by APPLICATION
  - 8.5.6.4.3. Market size and forecast, by TECHNOLOGY
  - 8.5.6.4.4. Market size and forecast, by END USER

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. ILLUMINA INC.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.1.7. Key strategic moves and developments
10.2. F. HOFFMANN-LA ROCHE AG
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
10.3. Qiagen N.V
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
- 10.3.7. Key strategic moves and developments
10.4. ABGI group
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
10.5. PerkinElmer, Inc
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
10.6. Agilent Technologies, Inc.
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.6.7. Key strategic moves and developments
10.7. Pacific Biosciences of California
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
10.8. Thermo Fisher Scientific Inc.
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
10.9. PRECIGEN INC
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
- 10.9.7. Key strategic moves and developments